Nutex Health, Inc.
Nutex Health, Inc.（NUTX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · NUTX · 截至 2026年6月8日
活动摘要
买入笔数
5
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
Nutex Health, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
NUTX 季度内部人买卖趋势
NUTX 内幕交易卖出 · NUTX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · NUTX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
NUTX 高管卖出股份 · NUTX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 4, 2026 | Spears Kelvin Director | Other | 2,519 | — | Form 4 |
| May 28, 2026 | Vo Thomas T. CEO · Director | Other | 75,747 | — | Form 4 |
| Apr 9, 2026 | Vo Thomas T. CEO · Director | Other | 184,071 | — | Form 4 |
| Mar 19, 2026 | Hosseinion Warren President · Director | Purchase | 252 | $24K | Form 4 |
| Mar 20, 2026 | Jaumot Frank E Director | Purchase | 150 | $14K | Form 4 |
| Mar 17, 2026 | Spears Kelvin Director | Purchase | 10 | $945 | Form 4 |
| Mar 13, 2026 | Montgomery Pamela W. Chief Legal Officer-Healthcare | Purchase | 79 | $7K | Form 4 |
| Mar 10, 2026 | Luqman Elisa V Chief Legal Officer - SEC | Option | 2,084 | — | Form 4 |
| Mar 10, 2026 | Luqman Elisa V Chief Legal Officer - SEC | Other | 784 | $68K | Form 4 |
| Mar 10, 2026 | Montgomery Pamela W. Chief Legal Officer-Healthcare | Option | 2,084 | — | Form 4 |
| Mar 10, 2026 | Montgomery Pamela W. Chief Legal Officer-Healthcare | Other | 776 | $67K | Form 4 |
| Mar 10, 2026 | Spears Kelvin Director | Option | 183 | — | Form 4 |
| Mar 10, 2026 | Spears Kelvin Director | Other | 82 | $7K | Form 4 |
| Mar 10, 2026 | Chang Michael L. Chief Medical Officer | Option | 2,084 | — | Form 4 |
| Mar 10, 2026 | Chang Michael L. Chief Medical Officer | Other | 769 | $66K | Form 4 |
| Mar 10, 2026 | Hosseinion Warren President · Director | Option | 6,293 | — | Form 4 |
| Mar 10, 2026 | Hosseinion Warren President · Director | Other | 3,274 | $282K | Form 4 |
| Mar 10, 2026 | Vo Thomas T. CEO · Director | Option | 8,334 | — | Form 4 |
| Mar 10, 2026 | Vo Thomas T. CEO · Director | Other | 3,017 | $260K | Form 4 |
| Mar 10, 2026 | Bates Jon Christian CFO | Option | 2,667 | — | Form 4 |
| Nov 25, 2025 | Bates Jon Christian CFO | Purchase | 750 | $103K | Form 4 |
| Apr 8, 2025 | Bates Jon Christian CFO | Purchase | 1,000 | $82K | Form 4 |
| Mar 1, 2025 | Bates Jon Christian CFO | Option | 1,500 | — | Form 4 |
| Mar 1, 2025 | Bates Jon Christian CFO | Option | 111 | — | Form 4 |
| Mar 1, 2025 | Spears Kelvin Director | Option | 143 | — | Form 4 |
Montgomery Pamela W.
Chief Legal Officer-Healthcare
日期
Mar 13
股数
79
均价
$88.87
总金额
$7K
Montgomery Pamela W.
Chief Legal Officer-Healthcare
日期
Mar 10
股数
2,084
均价
—
总金额
—
Montgomery Pamela W.
Chief Legal Officer-Healthcare
日期
Mar 10
股数
776
均价
$86.22
总金额
$67K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 NUTX 内幕交易
NUTX 内幕交易
Nutex Health, Inc.（NUTX）内幕交易数据来源于公司内部人（包括Spears Kelvin (Director), Vo Thomas T. (CEO · Director), Hosseinion Warren (President · Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。NUTX内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Nutex Health, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
NUTX 内幕交易 · 5个问题Nutex Health, Inc.（NUTX）的内部人包括高管和董事，如Spears Kelvin (Director), Vo Thomas T. (CEO · Director), Hosseinion Warren (President · Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026